Corporate stocks see shifts in analyst ratings and price targets

Various companies are seeing shifts in analyst ratings and price targets following recent financial disclosures and market evaluations.

Freedom Broker upgraded PepsiCo to ‘Buy’ while lowering its price target from 162 to 147 USD, citing brand strength but requiring better North American performance. AtriCure was downgraded from ‘Buy’ to ‘Hold’ by Freedom Capital, which raised its price target to 57 USD based on 2027 projections. Fiserv also saw price target reductions from TD Cowen and Barclays, with TD Cowen setting a target of 49 USD.

In other developments, AVITA Medical’s fair value rose to 12.29 USD following a revenue growth assessment. Meanwhile, Haverty Furniture Companies’ stock remains approximately 18.96 percent below the consensus target of 33.00 USD.